Src activity is increased in gastrointestinal stromal tumors - Analysis of associations with clinical and other molecular tumor characteristics

Journal of Surgical Oncology

Volumn 109, Issue 6, 2014, Pages 597-605

  Rotert, Julia Valerie ^a   Leupold, Jörg ^a   Hohenberger, Peter ^a   Nowak, Kai ^a   Allgayer, Heike ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

GIST; imatinib; sarcoma

Indexed keywords

BETA ACTIN; IMATINIB; PROTEIN TYROSINE KINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; AUTOPHOSPHORYLATION; CANCER CELL CULTURE; CANCER GROWTH; CANCER LOCALIZATION; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; WESTERN BLOTTING;

GIST; IMATINIB; SARCOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BENZAMIDES; EXONS; GASTROINTESTINAL NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PIPERAZINES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SRC-FAMILY KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898822751     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23544     Document Type: Article

References (37)

1. Allgayer H, Boyd DD, Heiss MM, et al.: Activation of Src kinase in primary colorectal carcinoma: An indicator of poor clinical prognosis. Cancer 2002; 94: 344-351.
2. Shor AC, Keschman EA, Lee FY, et al.: Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival. Cancer Res 2007; 67: 2800-2808.
3. Jacobs C, Rubsamen H:, Expression of pp60c-src protein kinase in adult and fetal human tissue: High activities in some sarcomas and mammary carcinomas. Cancer Res 1983; 43: 1696-1702.
4. Lutz MP, Esser IB, Flossmann-Kast BB, et al.: Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun 1998; 243: 503-508.
5. Benistant C, Chapuis H, Mottet N, et al.: Deregulation of the cytoplasmic tyrosine kinase cSrc in the absence of a truncating mutation at codon 531 in human bladder carcinoma. Biochem Biophys Res Commun 2000; 273: 425-430.
6. Mazurenko NN, Kogan EA, Zborovskaya IB, et al.: Expression of pp60c-src in human small cell and non-small cell lung carcinomas. Eur J Cancer 1992; 28: 372-377.
7. Wiener JR, Nakano K, Kruzelock RP, et al.: Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model. Clin Cancer Res 1999; 5: 2164-2170.
8. Cartwright CA, Meisler AI, Eckhart W:, Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci USA 1990; 87: 558-562.
9. Han NM, Curley SA, Gallick GE:, Differential activation of pp60(c-src) and pp62(c-yes) in human colorectal carcinoma liver metastases. Clin Cancer Res 1996; 2: 1397-1404.
10. Termuhlen PM, Curley SA, Talamonti MS, et al.: Site-specific differences in pp60c-src activity in human colorectal metastases. J Surg Res 1993; 54: 293-298.
11. Gold JS, Reynolds AB, Rimm DL:, Loss of p120ctn in human colorectal cancer predicts metastasis and poor survival. Cancer Lett 1998; 132: 193-201.
12. Wang HC, Erikson RL:, Activation of protein serine/threonine kinases p42, p63, and p87 in Rous sarcoma virus-transformed cells: signal transduction/transformation-dependent MBP kinases. Mol Biol Cell 1992; 3: 1329-1337.
13. Eliceiri BP, Paul R, Schwartzberg PL, et al.: Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 1999; 4: 915-924.
14. Thomas SM, Brugge JS:, Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997; 13: 513-609.
15. Roskoski R Jr.:, Signaling by Kit protein-tyrosine kinase-the stem cell factor receptor. Biochem Biophys Res Commun 2005; 337: 1-13.
16. Allgayer H, Wang H, Gallick GE, et al.: Transcriptional induction of the urokinase receptor gene by a constitutively active Src. Requirement of an upstream motif (-152/-135) bound with Sp1. J Biol Chem 1999; 274: 18428-18437.
17. Summy JM, Gallick GE:, Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003; 22: 337-358.
18. Kopetz S, Shah AN, Gallick GE:, Src continues aging: current and future clinical directions. Clin Cancer Res 2007; 13: 7232-7236.
19. Daud AI, Krishnamurthi SS, Saleh MN, et al.: Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors. Clin Cancer Res 2012; 18: 1092-1100.
20. Puls LN, Eadens M, Messersmith W:, Current status of SRC inhibitors in solid tumor malignancies. Oncologist 16: 566-578.
21. Gramza AW, Corless CL, Heinrich MC:, Resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumors. Clin Cancer Res 2009; 15: 7510-7518.
22. Rous P:, A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J Exp Med 1911; 13: 397-411.
23. Oppermann H, Levinson AD, Varmus HE, et al.: Uninfected vertebrate cells contain a protein that is closely related to the product of the avian sarcoma virus transforming gene (src). Proc Natl Acad Sci USA 1979; 76: 1804-1808.
24. Ellis LM, Staley CA, Liu W, et al.: Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. J Biol Chem 1998; 273: 1052-1057.
25. Leupold JH, Yang HS, Colburn NH, et al.: Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 2007; 26: 4550-4562.
26. Maurer GD, Leupold JH, Schewe DM, et al.: Analysis of specific transcriptional regulators as early predictors of independent prognostic relevance in resected colorectal cancer. Clin Cancer Res 2007; 13: 1123-1132.
27. Niedergethmann M, Alves F, Neff JK, et al.: Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer 2007; 97: 1432-1440.
28. Remmele W, Stegner HE:, [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987; 8: 138-140.
29. Casali PG, Jost L, Reichardt P, et al.: Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 (Suppl. 2): ii35-ii38.
30. Rossi F, Yozgat Y, de Stanchina E, et al.: Imatinib upregulates compensatory integrin signaling in a mouse model of gastrointestinal stromal tumor and is more effective when combined with dasatinib. Mol Cancer Res 2010; 8: 1271-1283.
31. Qayyum T, Fyffe G, Duncan M, et al.: The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder. Br J Cancer 106: 1187-1195.
32. Thomas S, Overdevest JB, Nitz MD, et al.: Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer. Cancer Res 71: 832-841.
33. Lesslie DP, Summy JM, Parikh NU, et al.: Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases. Br J Cancer 2006; 94: 1710-1717.
34. Wang TB, Qiu WS, Wei B, et al.: Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors. Ir J Med Sci 2009; 178: 315-320.
35. McAuliffe JC, Lazar AJ, Yang D, et al.: Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate. Clin Cancer Res 2007; 13: 6727-6734.
36. Duensing A, Medeiros F, McConarty B, et al.: Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs). Oncogene 2004; 23: 3999-4006.
37. Campbell EJ, McDuff E, Tatarov O, et al.: Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer. Br J Cancer 2008; 99: 1769-1774.